These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23664235)

  • 1. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    Xu Q; Pan J; Yu J; Liu X; Liu L; Zuo X; Wu P; Deng H; Zhang J; Ji A
    Diabetes Res Clin Pract; 2013 Aug; 101(2):99-105. PubMed ID: 23664235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Li MX; Wang Y; Wang Y
    Neurosci Lett; 2015 May; 594():23-9. PubMed ID: 25800109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Xu LC; Jiang LL; Li MX; Wang Y
    Medicine (Baltimore); 2018 Jul; 97(27):e11390. PubMed ID: 29979431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy.
    Deng H; Yin J; Zhang J; Xu Q; Liu X; Liu L; Wu Z; Ji A
    Endocrine; 2014 Aug; 46(3):445-54. PubMed ID: 24522613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of prostaglandin E1 plus lipoic acid combination therapy versus monotherapy for patients with diabetic peripheral neuropathy.
    Jiang DQ; Li MX; Ma YJ; Wang Y; Wang Y
    J Clin Neurosci; 2016 May; 27():8-16. PubMed ID: 26775115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy: A meta-analysis of randomized controlled trials.
    Jiang DQ; Zhao SH; Li MX; Jiang LL; Wang Y; Wang Y
    Medicine (Baltimore); 2018 Nov; 97(44):e13020. PubMed ID: 30383660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
    Wang XT; Lin HX; Xu SA; Lu YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He S; Pan YN; Zhang ZY
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e9. PubMed ID: 25052901
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He F; Zhang Y; Sun L
    Diabetes Res Clin Pract; 2014 May; 104(2):e33. PubMed ID: 24602352
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of epalrestat plus α-lipoic acid combination therapy
    Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
    Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
    Wang X; Lin H; Xu S; Jin Y; Zhang R
    Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
    Ran GL; Li YP; Lu LC; Lan SH
    J Diabetes Complications; 2024 Feb; 38(2):108691. PubMed ID: 38330524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sawangjit R; Thongphui S; Chaichompu W; Phumart P
    J Altern Complement Med; 2020 Dec; 26(12):1117-1129. PubMed ID: 32716261
    [No Abstract]   [Full Text] [Related]  

  • 15. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
    Han T; Bai J; Liu W; Hu Y
    Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are herbal medicines alone or in combination for diabetic peripheral neuropathy more effective than methylcobalamin alone? A systematic review and meta-analysis.
    Lee CW; Jin JS; Kwon S; Jin C; Cho SY; Park SU; Jung WS; Moon SK; Park JM; Ko CN; Cho KH
    Complement Ther Clin Pract; 2022 Nov; 49():101657. PubMed ID: 36007447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats.
    Yao H; Feng J; Zheng Q; Wei Y; Wang S; Feng W
    Life Sci; 2016 Sep; 161():60-8. PubMed ID: 27496624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
    Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.